Mao Zhang
5PUBLICATIONS
55CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 08, 2026
Arachidonic Acid Metabolism in PMN-MDSCs Suppresses Antitumor Capacity of T Cells in KRAS-Mutant Cholangiocarcinoma.Jian Lin, Chen Sang, Bin Xiang
|Jan 24, 2025
Mutant KRAS and CK2 Cooperatively Stimulate SLC16A3 Activity to Drive Intrahepatic Cholangiocarcinoma Progression.Ran Chen, Cuihong Ma, Haoran Qian
|Jul 24, 2023
An Inflammatory Checkpoint Generated by IL1RN Splicing Offers Therapeutic Opportunity for KRAS-Mutant Intrahepatic Cholangiocarcinoma.Mao Zhang, Yingying Huang, Jiaomeng Pan
|Jul 19, 2022
Geospatial Immune Heterogeneity Reflects the Diverse Tumor-Immune Interactions in Intrahepatic Cholangiocarcinoma.Youpei Lin, Lihua Peng, Liangqing Dong
|Jan 08, 2020
High Inflammatory Factor Grading Predicts Poor Disease-Free Survival in AJCC Stage I-II Hepatocellular Carcinoma Patients After R0 Resection.Mao Zhang, Mei-Sze Chua, Jie Hu
Pageof 1
